ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Rigel Pharmaceuticals Inc

Rigel Pharmaceuticals Inc (RIGL)

26.49
-0.56
(-2.07%)
Closed 05 December 8:00AM
26.49
0.00
(0.00%)
After Hours: 9:07AM

Income Statement

Balance Sheet

Cash Flow

Quarter End Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 29.82M22.41M51.28M26.07M26.89M28.13M35.79M29.53M
Operating Income -12.97M-18.4M2.08M-12.73M-5.27M-4.47M1.97M-6.97M
Pre Tax Income -13.49M-19.04M1.4M-13.54M-6.6M-5.69M737k-8.25M
Net Income -13.49M-19.04M1.4M-13.54M-6.6M-5.69M737k-8.25M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -12.97M-18.4M2.08M-12.73M-5.27M-4.47M1.97M-6.97M
EBITDA -12.73M-18.16M2.36M-12.37M-4.97M-4.17M2.32M-6.57M
Year End 31 December 2023 20162017201820192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 20.38M4.48M44.51M59.29M108.62M149.24M120.24M116.88M
Operating Income -69.74M-79.62M-72.68M-69.09M-28.97M-12.5M-55.55M-20.49M
Pre Tax Income -69.22M-77.99M-70.48M-66.89M-29.74M-17.31M-58.57M-25.09M
Net Income -69.22M-77.99M-70.48M-66.89M-29.74M-17.91M-58.57M-25.09M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) -0.697-0.531-0.422-0.398-0.176-0.104-0.338-0.144
EBIT -69.65M-78.88M-72.68M-69.09M-28.97M-12.5M-55.55M-20.49M
EBITDA -68.8M-79.15M-72.09M-68.41M-28.27M-11.33M-54.55M-19.19M

Your Recent History

Delayed Upgrade Clock